This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Ehrlichia Antigen
Product Overview
BioVenic's Recombinant Ehrlichia Antigen is a recombinant antigen produced by E.coli. This antigen has undergone a rigorous purification process. It can be used for ELISA plate coating or for the preparation of enzyme conjugates.
Specifications
Target Information
Ehrlichia is a genus of obligate intracellular, Gram-negative rickettsial bacteria transmitted by ixodid ticks, primarily causing ehrlichiosis in humans and canines. They target and replicate inside the vacuoles of hematopoietic cells, forming microcolonies called morulae. Key targets for serological diagnostics and therapeutic research include major outer membrane proteins-specifically the 28-kDa outer membrane protein family (OMP-1/P28)-and tandem repeat proteins (such as TRP120 and TRP32), which play critical roles in host cell entry, adhesion, and immune evasion.
Shipping and Storage
This product is shipped with gel ice bags. Store at 0-4°C for no more than 2 weeks, or -20°C or below for long-term storage.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquote the reconstituted solution to minimise freeze-thaw cycles.